Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China: a multicentre, retrospective cohort study

CONCLUSION: Among hospitalized patients with COVID-19 during the Omicron wave in Beijing, China, the early initiation of nirmatrelvir-ritonavir was associated with clinical benefits of lowering mortality and improving clinical recovery.PMID:38354691 | PMC:PMC10868413 | DOI:10.1080/07853890.2024.2313062

Source: Annals of Medicine - February 14, 2024 Category: Internal Medicine Authors: Xiaobo Han Chenglong Li Xin Yuan Junchang Cui Zhihai Han Jiguang Meng Weiguo Zhao Fei Xie Kaifei Wang Yuhong Liu Guoxin Muo Na Xi Mengli Zheng Rentao Wang Kun Xiao Wei Chen Junchen Xiong Dahui Zhao Xinxin Zhang Xinjie Han Haibo Cheng Zhongkuo Yu Yinghan S Source Type: research